Unknown

Dataset Information

0

A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.


ABSTRACT: Nonalcoholic fatty liver disease (NAFLD) is a common liver disease that can progress to cirrhosis and liver failure. Anthocyanin, a member of the flavonoid family, has been shown to ameliorate NAFLD-associated pathologies in rodents.The aim of this CONSORT-compliant pilot study is to evaluate the effects of anthocyanin supplementation on insulin resistance and liver injury biomarkers in patients with NAFLD.A total of 74 subjects with NAFLD were divided into 2 groups in this double-blind, randomized study. Patients received either purified anthocyanin (320?mg/d) derived from bilberry and black currant or placebo for 12 weeks. Diet, physical activity, anthropometric parameters, glucose tolerance, and a set of biomarkers related to NAFLD were evaluated before and after intervention.No significant differences were observed in nutrient intake, physical activity, anthropometric parameters, or plasma lipid profile between patients receiving anthocyanin or placebo. Compared to controls, the anthocyanin group exhibited significant decreases (P?

SUBMITTER: Zhang PW 

PROVIDER: S-EPMC4602870 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.

Zhang Pei-Wen PW   Chen Feng-Xia FX   Li Di D   Ling Wen-Hua WH   Guo Hong-Hui HH  

Medicine 20150501 20


Nonalcoholic fatty liver disease (NAFLD) is a common liver disease that can progress to cirrhosis and liver failure. Anthocyanin, a member of the flavonoid family, has been shown to ameliorate NAFLD-associated pathologies in rodents.The aim of this CONSORT-compliant pilot study is to evaluate the effects of anthocyanin supplementation on insulin resistance and liver injury biomarkers in patients with NAFLD.A total of 74 subjects with NAFLD were divided into 2 groups in this double-blind, randomi  ...[more]

Similar Datasets

| S-EPMC4834197 | biostudies-literature
| S-EPMC7837859 | biostudies-literature
| S-EPMC6450966 | biostudies-literature
| S-EPMC3162484 | biostudies-literature
| S-EPMC4147029 | biostudies-literature
| S-EPMC7505320 | biostudies-literature
| S-EPMC9135169 | biostudies-literature
| S-EPMC3362909 | biostudies-literature
| S-EPMC5038350 | biostudies-literature
| S-EPMC6484692 | biostudies-literature